CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Cubist Pharmaceuticals Inc. v. Hospira Inc.

1:12-cv-00367

Overview

Case Number 1:12-cv-00367
Filing Date 2012-03-21
Status Terminated
Termination Date 2014-12-08
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Plaintiff

Hospira Inc. Operating Company

Represented By

11 Attorneys Listed

Stephen R. Smerek

UNDELIVERABLE EMAIL 2/26/2020

Peter E. Perkowski

UNDELIVERABLE EMAIL 7/8/15

Neema A. Kumar

UNDELIVERABLE EMAIL 2/5/2016

Jovial Wong

Email: jwong@winston.com

James F. Hurst

Email: james.hurst@kirkland.com

Gail J Standish

UNDELIVERABLE EMAIL 3/26/15

David P. Dalke

Email: ddalke@winston.com

Christopher Bruno

Email: cbruno@schiffhardin.com

Ashlea Raymond Pflug

UNDELIVERABLE EMAIL 1/27/2017

Megan C. Haney

Phillips, Goldman, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Cubist Pharmaceuticals Inc. Operating Company

Represented By

3 Attorneys Listed

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 3 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials 10 proceedings
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (3): πŸ‡―πŸ‡΅ Japan πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (10 found):
PTAB: 10
USPTO PTAB Trial 2015-07-10
IPR2015-01572

Fresenius Kabi USA LLC v. Cubist Pharmaceuticals LLC et al.

U.S. Continuation Sibling (8058238)
Status: Institution Denied
USPTO PTAB Trial 2015-07-10
IPR2015-01571

Fresenius Kabi USA LLC v. Cubist Pharmaceuticals LLC

U.S. Continuation Sibling (8058238)
Status: Terminated-Settled
USPTO PTAB Trial 2015-07-10
IPR2015-01570

Fresenius Kabi USA LLC v. Cubist Pharmaceuticals LLC

U.S. Continuation Sibling (8058238)
Status: Terminated-Settled
USPTO PTAB Trial 2015-07-10
IPR2015-01566

Fresenius Kabi USA LLC v. Cubist Pharmaceuticals LLC

U.S. Continuation Sibling (8129342)
Status: Terminated-Settled
USPTO PTAB Trial 2014-11-03
IPR2015-00227

Fresenius-Kabi USA LLC v. Cubist Pharmaceuticals LLC et al.

Asserted Patent
Status: Final Written Decision
USPTO PTAB Trial 2014-11-03
IPR2015-00223

Fresenius-Kabi USA LLC v. Cubist Pharmaceuticals LLC et al.

U.S. Continuation Sibling (6852689)
Status: Final Written Decision
USPTO PTAB Trial 2014-10-24
IPR2015-00144

Agila Specialties Inc. et al. v. Cubist Pharmaceuticals, Inc. et al.

U.S. Continuation Sibling (8058238)
Status: Institution Denied
USPTO PTAB Trial 2014-10-23
IPR2015-00143

Agila Specialities Inc. et al. v. Cubist Pharmaceuticals, Inc. et al.

U.S. Continuation Sibling (8058238)
Status: Institution Denied
USPTO PTAB Trial 2014-10-23
IPR2015-00142

Agila Specialities Inc. et al. v. Cubist Pharmaceuticals, Inc. et al.

U.S. Continuation Sibling (8058238)
Status: Institution Denied
USPTO PTAB Trial 2014-10-23
IPR2015-00141

Agila Specialities Inc. et al. v. Cubist Pharmaceuticals, Inc. et al.

U.S. Continuation Sibling (8058238)
Status: Institution Denied
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

7 Patents

There are 7 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6648967
Crystal-pulling apparatus for pulling and growing a monocrystalline silicon ingot, and method therefor
Filed: 2001-11-20
Issued: 2003-11-18
Expired (Term Ended)
Expires: 2021-11-20
US6852689
Methods for administration of antibiotics
Filed: 2002-02-20
Issued: 2005-02-08
Expired (Term Ended)
Expires: 2022-02-20
USRE39071
Anhydro-and isomer-a-21978c cyclic peptides
Filed: 2000-04-11
Issued: 2006-04-18
Expired (Term Ended)
Expires: 2020-04-11
US8058238
High purity lipopeptides
Filed: 2007-04-24
Issued: 2011-11-15
Expiring Soon (155 days)
Expires: 2027-04-24
US6468967
Methods for administration of antibiotics
Filed: 1999-09-24
Issued: 2002-10-22
Expired (Term Ended)
Expires: 2019-09-24

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

25

Dispositive

1

Granted

0

Denied

1

Pending / Review

18

Motions by Category

Procedural / Extension Motion 8 Claim Construction / Markman Filing 16 Motion for Summary Judgment (Rule 56) 1

Key Dispositive Motions & Rulings

Motion for Summary Judgment (Rule 56) Denied
ORDER DENYING 101 Defendant's Letter Request to file a Motion for Summary Judgment. Signed by Chief Judge Gregory M. Sleet on 1/15/14. (mmm) (Entered: 01/15/201...
Entry #107 • 2014-01-15 Document →
Procedural / Extension Motion Pending
SO ORDERED, re 98 STIPULATION TO EXTEND TIME for Expert Discovery Deadlines to Dates Referenced in Stipulation filed by Cubist Pharmaceuticals Inc., Hospira Inc...
Entry #β€” • 2013-09-10
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for Expert Discovery Deadlines to Dates Referenced in Stipulation - filed by Cubist Pharmaceuticals Inc., Hospira Inc.. (Phillips, Jo...
Entry #98 • 2013-08-29 Document →
Procedural / Extension Motion Pending / Under Review
SO ORDERED, re 73 Joint STIPULATION TO EXTEND TIME for Certain Fact and Expert Discovery Deadlines to Various Proposed Amended Dates filed by Hospira Inc., ORDE...
Entry #74 • 2013-06-19 Document →
Procedural / Extension Motion Pending / Under Review
Joint STIPULATION TO EXTEND TIME for Certain Fact and Expert Discovery Deadlines to Various Proposed Amended Dates - filed by Hospira Inc.. (Phillips, John) (En...
Entry #73 • 2013-06-18 Document →
Claim Construction / Markman Filing Pending
Minute Entry for proceedings held before Judge Gregory M. Sleet - Markman Hearing held on 4/10/2013. Counsel Claim Construction Presentations. The court will ta...
Entry #β€” • 2013-04-10

Docket Entries

(214 total)
Pleading / Complaint

COMPLAINT filed against Hospira Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-1043346.) - filed by Cubist Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A-D, # 2 Civil Cover Sheet)(els) (Entered: 03/22/2012)

Entry #1 • 2012-03-21
1
Pleading / Complaint

COMPLAINT filed against Hospira Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-1043346.) - filed by Cubist Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A-D, # 2 Civil Cover Sheet)(els) (Entered: 03/22/2012)

Entry #1 • 2012-03-21
2
Pleading / Complaint

COMPLAINT filed against Hospira Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-1043346.) - filed by Cubist Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A-D, # 2 Civil Cover Sheet)(els) (Entered: 03/22/2012)

Entry #1 • 2012-03-21
2

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 2/7/12. Date of Expiration of Patent: 11/29/20.Thirty Month Stay Deadline: 8/7/2014. (els) (Entered: 03/22/2012)

Entry #2 • 2012-03-21
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,648,967 B1; 6,852,689 B2; RE39,071 E; 8,058,238 B2;. (els) (Entered: 03/22/2012)

Entry #3 • 2012-03-21
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc